Clinical Trials Browser

Carcinoma, Merkel Cell

NCT04869137 2026-04-08

Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma

Phase 2 Active not recruiting

26 enrolled 9 charts

Dermatologic

Skin Neoplasms, Carcinoma, Merkel Cell

NCT03071406 2026-03-11

Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma

Phase 2 Active not recruiting

50 enrolled 12 charts

Dermatologic

Neoplasm Metastasis, Skin Neoplasms, Carcinoma, Merkel Cell

NCT04916002 2025-12-05

A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer

Phase 2 Terminated

77 enrolled 18 charts

BreastDermatologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Basal Cell, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Carcinoma, Merkel Cell, Triple Negative Breast Neoplasms

NCT03599713 2025-08-05

A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201)

Phase 2 Completed

107 enrolled 16 charts 2 FDA

Dermatologic

Carcinoma, Merkel Cell

NCT02819843 2025-01-29

A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors

Phase 2 Completed

19 enrolled 7 charts

Dermatologic

Melanoma, Carcinoma, Merkel Cell

NCT03853317 2024-08-09

QUILT-3.063: A Study of N-803, haNK and Avelumab in Patients With Merkel Cell Carcinoma That Has Progressed After Checkpoint Therapy

Phase 2 Terminated

9 enrolled 13 charts

Dermatologic

Carcinoma, Merkel Cell

NCT02465957 2024-05-02

QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC)

Phase 2 Terminated

7 enrolled 11 charts

Dermatologic

Carcinoma, Merkel Cell

NCT02155647 2024-03-13

Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200)

Phase 2 Completed

204 enrolled 32 charts

Dermatologic

Carcinoma, Merkel Cell

NCT02267603 2023-07-05

Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer

Phase 2 Completed

50 enrolled 11 charts 2 FDA

Dermatologic

Carcinoma, Merkel Cell

NCT01440816 2023-05-15

MCC

Phase 2 Completed

15 enrolled 13 charts

Dermatologic

Carcinoma, Merkel Cell

NCT02036476 2023-05-09

Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma

Phase 2 Terminated

8 enrolled 7 charts

Dermatologic

Skin Neoplasms, Carcinoma, Merkel Cell

NCT03988647 2021-08-09

Palliative RT & Anti-PD-1/PD-L1 Checkpoint Blockade in Metastatic Merkel Cell Carcinoma

Phase 2 Terminated

1 enrolled 7 charts

Dermatologic

Carcinoma, Merkel Cell

Clinical Trials

Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell Carcinoma

Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma

Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma

A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer

A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201)

A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors

QUILT-3.063: A Study of N-803, haNK and Avelumab in Patients With Merkel Cell Carcinoma That Has Progressed After Checkpoint Therapy

QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC)

Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200)

Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer

MCC

Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma

Palliative RT & Anti-PD-1/PD-L1 Checkpoint Blockade in Metastatic Merkel Cell Carcinoma